Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001222801 | SCV001394918 | uncertain significance | Early infantile epileptic encephalopathy with suppression bursts | 2019-08-21 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with SCN1A-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with isoleucine at codon 367 of the SCN1A protein (p.Thr367Ile). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and isoleucine. |
Institute of Human Genetics, |
RCV004584427 | SCV002577754 | uncertain significance | See cases | 2021-12-16 | criteria provided, single submitter | clinical testing | ACMG categories: PM2,PP3 |
Diagnostic Laboratory, |
RCV002275319 | SCV002562856 | uncertain significance | Seizure | no assertion criteria provided | clinical testing |